• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why The Fear Level Among US Investors Is Easing

    10/10/23 9:00:14 AM ET
    $NEOG
    $NWLI
    $PEP
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Life Insurance
    Finance
    Get the next $NEOG alert in real time by email

    The CNN Money Fear and Greed index showed further easing in the fear level, but the index remained in the "Fear" zone on Tuesday.

    U.S. stocks settled higher on Monday, despite the ongoing conflict between Israel and the Palestinian militant group Hamas. Crude oil futures gained more than 4% on Monday, while defense stocks rose sharply amid the conflict in the Middle East.

    The bond market was closed on Monday for the Columbus Day holiday.

    National Western Life Group, Inc. (NASDAQ:NWLI) shares gained more than 16% on Monday after the company inked a definitive merger deal with Prosperity Life Group for about $1.9 billion in an all-cash transaction.

    The Dow Jones closed higher by around 197 points to 33,604.65 on Monday. The S&P 500 rose 0.63% at 4,335.66, while the Nasdaq Composite gained 0.39% at 13,484.24 during Monday’s session.

    At a current reading of 29.8, the index remained in the "Fear" zone on Monday, compared to a previous reading of 26.

    What is CNN Business Fear & Greed Index?

    The Fear & Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.

    Read Next: Walgreens Likely To Report Lower Q4 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

    Get the next $NEOG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NEOG
    $NWLI
    $PEP

    CompanyDatePrice TargetRatingAnalyst
    PepsiCo Inc.
    $PEP
    1/16/2026$179.00Neutral → Outperform
    BNP Paribas Exane
    PepsiCo Inc.
    $PEP
    12/10/2025$164.00Neutral → Overweight
    Analyst
    PepsiCo Inc.
    $PEP
    10/21/2025$167.00Hold → Buy
    DZ Bank
    Neogen Corporation
    $NEOG
    7/29/2025Outperform → Mkt Perform
    William Blair
    PepsiCo Inc.
    $PEP
    4/15/2025$155.00Buy → Neutral
    BofA Securities
    PepsiCo Inc.
    $PEP
    3/18/2025$168.00 → $156.00Overweight → Equal Weight
    Barclays
    PepsiCo Inc.
    $PEP
    3/12/2025$171.00 → $170.00Buy → Hold
    Jefferies
    PepsiCo Inc.
    $PEP
    1/7/2025$171.00Overweight
    Piper Sandler
    More analyst ratings

    $NEOG
    $NWLI
    $PEP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Nassif Mikheal bought $486 worth of shares (49 units at $9.93) (SEC Form 4)

    4 - NEOGEN CORP (0000711377) (Issuer)

    2/2/26 4:36:07 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    CEO Nassif Mikheal bought $1,279 worth of shares (137 units at $9.33) (SEC Form 4)

    4 - NEOGEN CORP (0000711377) (Issuer)

    1/16/26 9:04:01 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    CEO Nassif Mikheal bought $1,106 worth of shares (177 units at $6.25) (SEC Form 4)

    4 - NEOGEN CORP (0000711377) (Issuer)

    11/7/25 12:20:20 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $NEOG
    $NWLI
    $PEP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Nassif Mikheal bought $486 worth of shares (49 units at $9.93) (SEC Form 4)

    4 - NEOGEN CORP (0000711377) (Issuer)

    2/2/26 4:36:07 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: Senior Vice President Ranalli Tamara A. was granted 101,626 shares (SEC Form 4)

    4/A - NEOGEN CORP (0000711377) (Issuer)

    1/29/26 10:30:09 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Senior Vice President Ranalli Tamara A. was granted 50,813 shares (SEC Form 4)

    4 - NEOGEN CORP (0000711377) (Issuer)

    1/26/26 9:34:27 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $NEOG
    $NWLI
    $PEP
    SEC Filings

    View All

    SEC Form 10-Q filed by Neogen Corporation

    10-Q - NEOGEN CORP (0000711377) (Filer)

    1/8/26 4:07:39 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Neogen Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - NEOGEN CORP (0000711377) (Filer)

    1/8/26 7:03:05 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    PepsiCo Inc. filed SEC Form 8-K: Leadership Update

    8-K - PEPSICO INC (0000077476) (Filer)

    12/15/25 8:00:55 AM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    $NEOG
    $NWLI
    $PEP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $NEOG
    $NWLI
    $PEP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    PepsiCo Declares Quarterly Dividend

    PURCHASE, N.Y., Feb. 4, 2026 /PRNewswire/ -- The Board of Directors of PepsiCo, Inc. (NASDAQ:PEP) today declared a quarterly dividend of $1.4225 per share of PepsiCo common stock, a 5 percent increase versus the comparable year-earlier period. Today's action is consistent with PepsiCo's prior year, previously announced increase in its annualized dividend to $5.69 per share from $5.42 per share, which began with the June 2025 payment. This dividend is payable on March 31, 2026 to shareholders of record at the close of business on March 6, 2026. In addition, on February 3, 2026,

    2/4/26 4:20:00 PM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution

    Neogen Corporation (NASDAQ:NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following intraarticular injections of this product, which is inconsistent with its labeled, intended use. To date, Neogen has not received reports of adverse events when used in a manner consistent with the labeled use. While the company's

    1/28/26 6:27:00 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Neogen Announces Second-Quarter 2026 Results

    Revenue of $224.7 million, a decrease of 2.8% YoY; Core growth1 increased 2.9% YoY Net loss of $15.9 million; Adjusted Net Income1 of $22.6 million Adjusted EBITDA1 of $48.7 million; Adjusted EBITDA margin1 increased 470 bps sequentially Company hires key senior commercial leaders Petrifilm manufacturing transition remains on track Raising FY 2026 revenue and Adjusted EBITDA guidance 1 Non-GAAP financial measures; see explanations and reconciliations that follow Neogen Corporation (NASDAQ:NEOG) announced today the results of the second quarter ended November 30, 2025. "I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic tr

    1/8/26 7:00:00 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    PepsiCo upgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane upgraded PepsiCo from Neutral to Outperform and set a new price target of $179.00

    1/16/26 8:56:28 AM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    PepsiCo upgraded by Analyst with a new price target

    Analyst upgraded PepsiCo from Neutral to Overweight and set a new price target of $164.00

    12/10/25 8:12:34 AM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    PepsiCo upgraded by DZ Bank with a new price target

    DZ Bank upgraded PepsiCo from Hold to Buy and set a new price target of $167.00

    10/21/25 7:14:10 AM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    $NEOG
    $NWLI
    $PEP
    Leadership Updates

    Live Leadership Updates

    View All

    PepsiCo, Griffith Foods, and Milhão Launch Direct Farmer Incentive Pilot Program in Brazil's Cerrado Region to Advance Regenerative Agriculture

    A pioneering hybrid "Payment for Practice and Payment for Outcomes" model, directly compensating farmers for adopting regenerative agriculture practicesLaunched in Brazil's Cerrado region, one of the world's most biodiverse savannas and a vital agricultural frontier that produces 60% of Brazil's soybeans and a substantial amount of cornThe pilot will cover 7,000 acres, with plans to scale to 30,000 acres, equivalent to PepsiCo's full corn sourcing volume in the region, with a total investment of $1 million over three years.This project aims to contribute to PepsiCo's efforts to spread the adoption of regenerative agriculture, protective and restorative practices across 10 million acres by 20

    11/3/25 8:30:00 AM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    Neogen® Corporation Announces Appointment of Bryan Riggsbee as Chief Financial Officer

    Neogen® Corporation (NASDAQ:NEOG), a global leader of food safety solutions, is pleased to announce the appointment of Bryan Riggsbee as its new Chief Financial Officer effective November 3, 2025. Riggsbee will oversee Neogen's global finance organization and join the company's Executive Leadership Team, reporting directly to Chief Executive Officer Mike Nassif. To ensure a smooth transition, David Naemura is expected to remain with the Company until the end of the calendar year. Riggsbee brings over 25 years of financial leadership experience across the diagnostics and healthcare industries. He joins Neogen from bioMérieux where he served as Chief Financial Officer of its $2 billion Nort

    10/30/25 8:45:00 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Celsius Holdings and PepsiCo Strengthen Long-Term Strategic Partnership

    Companies further align strategic energy partnership to better serve retailers and consumers Celsius Holdings' Alani Nu brand joins PepsiCo distribution system, opening access to new channels and broader distribution Celsius Holdings acquires the Rockstar Energy brand in the U.S. and Canada from PepsiCo, creating a total energy portfolio Celsius Holdings to host webcast at 8:30 a.m. ET today Celsius Holdings, Inc. (NASDAQ:CELH) ("Celsius Holdings") and PepsiCo, Inc. (NASDAQ:PEP) ("PepsiCo") today announced an agreement to strengthen their long-term strategic partnership. As part of the agreement: (i) Celsius Holdings' Alani Nu® brand will move into the PepsiCo distribution system in

    8/29/25 7:00:00 AM ET
    $CELH
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    $NEOG
    $NWLI
    $PEP
    Financials

    Live finance-specific insights

    View All

    PepsiCo Declares Quarterly Dividend

    PURCHASE, N.Y., Feb. 4, 2026 /PRNewswire/ -- The Board of Directors of PepsiCo, Inc. (NASDAQ:PEP) today declared a quarterly dividend of $1.4225 per share of PepsiCo common stock, a 5 percent increase versus the comparable year-earlier period. Today's action is consistent with PepsiCo's prior year, previously announced increase in its annualized dividend to $5.69 per share from $5.42 per share, which began with the June 2025 payment. This dividend is payable on March 31, 2026 to shareholders of record at the close of business on March 6, 2026. In addition, on February 3, 2026,

    2/4/26 4:20:00 PM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    Neogen Announces Second-Quarter 2026 Results

    Revenue of $224.7 million, a decrease of 2.8% YoY; Core growth1 increased 2.9% YoY Net loss of $15.9 million; Adjusted Net Income1 of $22.6 million Adjusted EBITDA1 of $48.7 million; Adjusted EBITDA margin1 increased 470 bps sequentially Company hires key senior commercial leaders Petrifilm manufacturing transition remains on track Raising FY 2026 revenue and Adjusted EBITDA guidance 1 Non-GAAP financial measures; see explanations and reconciliations that follow Neogen Corporation (NASDAQ:NEOG) announced today the results of the second quarter ended November 30, 2025. "I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic tr

    1/8/26 7:00:00 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Neogen Announces Second-Quarter Earnings Release Date

    Neogen® Corporation (NASDAQ:NEOG) will issue its second-quarter earnings release before the opening of the market on January 8, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North America: 1-800-549-8228 International: (+1) 646-564-2877 Conference ID: 82072 The live webcast can be accessed through Neogen's Investor Relations webpage, investors.neogen.com, under the "Events & Presentations" subheading. A replay of the conference call and webcast will be available shortly following the conclusion of the call and c

    12/18/25 9:00:00 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $NEOG
    $NWLI
    $PEP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Neogen Corporation

    SC 13G - NEOGEN CORP (0000711377) (Subject)

    11/14/24 4:28:12 PM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form SC 13G filed by Neogen Corporation

    SC 13G - NEOGEN CORP (0000711377) (Subject)

    11/14/24 11:16:20 AM ET
    $NEOG
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form SC 13G/A filed by National Western Life Group Inc. (Amendment)

    SC 13G/A - National Western Life Group, Inc. (0001635984) (Subject)

    2/14/24 3:04:14 PM ET
    $NWLI
    Life Insurance
    Finance